[1]Hug C, Wang J, Ahmad NS, et al.T-cadherin is a receptorfor hexameric and high-molecularweight forms ofAcrp30/adiponectin[J].Proc Natl Acad Sci U S A, 2004, 101 (28) :10308-10313.
|
[2]Kamada Y, Tamura S, Matsumoto H, et al.Enhancedcarbon tetrachloride-induced liver fibrosis in mice lackingadiponectin[J].Gastroenterology, 2003, 125 (6) :1796-1807.
|
[3]Handy JA, Saxena NK, Fu P, et al.Adiponectin activationof AMPK disrupts leptin-mediated hepatic fibrosis viasuppressors of cytokine signaling (SOCS-3) [J].J CellBiochem, 2010, 110 (5) :1195-1207.
|
[4]Asano T, Omata M, Kadowaki T, et al.Adiponectin knockoutmice on high fat diet develop fibrosing steatohepatitis[J].JGastroenterol Hepatol, 2009, 24 (10) :1669-1676.
|
[5]Kamada Y, Matsumoto H, Tamura S, et al.Hypoadip-onectinemia accelerates hepatic tumor formation in anonalcoholic steatohepatitis mouse model[J].J Hepatol, 2007, 47 (4) :556-564.
|
[6]Fukushima J, Kamada Y, Yoshida Y, et al.Adiponectinprevents progression of steatohepatitis in mice byregulating oxidative stress and Kupffer cell phenotypepolarizationhep[J].Hepatol Res, 2009, 39 (7) :724-738.
|
[7]Tomita K, Oike Y, Teratani T, et al.Hepatic AdipoR2 signalingplays a protective role against progression of nonalcoholicsteatohepatitis in mice[J].Hepatology, 2008, 48 (2) :458-473.
|
[8]You M, Rogers CQ.Adiponectin:a key adipokine in alcoholicfatty liver[J].Exp Biol Med, 2009, 234 (8) :850-859.
|
[9]Ding X, Saxena NK, Lin S, et al.The roles of leptin andadiponectin:a novel paradigm in adipocytokine regulation ofliver fibrosis and stellate cell biology[J].Am J Pathol, 2005, 166 (6) :1655-1669.
|
[10]Da Silva Morais A, Abarca-Quinones J, Guigas B, et al.Development of hepatic fibrosis occurs normally in AMPK-deficient mice[J].Clin Sci, 2009, 118 (6) :411-420.
|
[11]Zhang J, Tan L, Lin J, et al.Adenovirus-mediatedoverexpression of AMP-activated protein kinase inducesLX2 cell apoptosis[J].Nan Fang Yi Ke Da Xue Xue Bao, 2007, 27 (6) :821-823.
|
[12]Adach M, Brenneri DA.High molecular weight adip-onectininhibits proliferation of hepatic stellate cells via activationof adenosine monophosphate-activated protein kinase[J].Hepatology, 2008, 47 (2) :677-685.
|
[13]Urtasun R, Nieto N.Hepatic stellate cells and oxidativestress[J].Rev Esp Enferm Dig, 2007, 99 (4) :223-230.
|
[14]Aram G, Potter JJ, Liu X, et al.Lack of inducible nitricoxide synthase leads to increased hepatic apoptosis anddecreased fibrosis in mice after chronic carbon tetrachlorideadministration[J].Hepatology, 2008, 47 (6) :2051-2058.
|
[15]Liu YD, Ramezani-Moghadam M, George J, et al.Ku-pfferCells and s inusoidal endothelial cells mediate the anti-fibrogenic effects of adiponectin on hepatic stellate cells[R].Hepatol Int, 2010, 4 (1) :2-93.
|
[16]Musso G, Gambino R, Biroli G, et al.Hypoadiponec-tinemiapredicts the severity of hepatic fibrosis and pancreaticbeta-cell dysfunction in nondiabetic nonobese patients withnonalcoholic steatohepatitis[J].Am J Gastroenterol, 2005, 100 (11) :2438-2446.
|
[17]Kaser S, Moschen A, Cayon A, et al.Adiponectin and itsreceptors in nonalcoholic steatohepatitis[J].Gut, 2005, 54 (1) :117-121.
|
[18]Nazal L, Riquelme A, Soíls N, et al.Hypoadipone-ctinemiaand its association with liver fibrosis in morbidly obese patients[J].Obes Surg, 2010, 20 (10) :1400-1407.
|
[19]Wedemeyer I, Bechmann LP, Odenthal M, et al.Adip-onectininhibits steatotic CD95/Fas up-regulation by hepatocytes:Therapeutic implications for hepatitis C[J].J Hepatol, 2009, 50 (1) :140-149.
|
[20]Jonsson JR, Moschen AR, Hickman LJ, et al.Adiponectinand its receptors in patients with chronic hepatitis C[J].JHepatol, 2005, 43 (6) :929-936.
|
[21]Latif HA, Assal HS, Mahmoud M, et al.Role of serumadiponectin level in the development of liver cirrhosis inpatients with hepatitis C virus[J].Clin Exp Med, 2010, Aug17.[Epub ahead of print]
|
[22]Hui CK, Zhang HY, Lee NP, et al.Serum adiponectin isincreased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B[J].J Hepatol, 2007, 47 (2) :191-202.
|
[23]Liu CJ, Chen PJ, Lai MY, et al.High serum adiponectincorrelates with advanced liver disease in patients with chronichepatitis B virus infection[J].Hepatol Int, 2009, 3 (2) :364-370.
|
[24]Tacke F, Horn R, Luedde T, et al.High adiponectin in chronic liverdisease and cholestasis suggests biliary route of adiponectinexcretion in vivo[J].J Hepatol, 2005, 42 (5) :666-673.
|
[25]Wong VW, Wong GL, Yu J, et al.Interaction of adipokinesand hepatitis B virus on histological liver injury in theChinese[J].Am J Gastroenterol, 2010, 105 (1) :132-138.
|